As of 2026-11-10, the Intrinsic Value of Amniotics AB (publ) (AMNI.ST) is -0.06 SEK. This AMNI.ST valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 SEK, the upside of Amniotics AB (publ) is -1,145.84%.
Based on its market price of 0.01 SEK and our intrinsic valuation, Amniotics AB (publ) (AMNI.ST) is overvalued by 1,145.84%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.06 - -0.06 | -0.06 | -1,145.84% |
| P/E | 0.01 - 0.01 | 0.01 | 4.6% |
| DDM - Stable | (0.57) - 1.20 | 0.32 | 5739.3% |
| DDM - Multi | (1.06) - 1.68 | (5.33) | -98715.2% |
| Market Cap (mil) | 14.76 |
| Beta | -1.62 |
| Outstanding shares (mil) | 2,733.05 |
| Enterprise Value (mil) | 6.55 |
| Market risk premium | 5.10% |
| Cost of Equity | 3.27% |
| Cost of Debt | 5.00% |
| WACC | 3.38% |